.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
Chinese Patent Office
US Army
Federal Trade Commission
Boehringer Ingelheim
Fuji
Moodys
Chubb
Dow
Fish and Richardson

Generated: December 18, 2017

DrugPatentWatch Database Preview

Ucb Inc Company Profile

« Back to Dashboard

What is the competitive landscape for UCB INC, and what generic alternatives to UCB INC drugs are available?

UCB INC has forty-eight approved drugs.

There are fifteen US patents protecting UCB INC drugs on UCB INC drugs in the past three years.

There are three hundred and eighteen patent family members on UCB INC drugs in forty-seven countries and thirty-six supplementary protection certificates in eleven countries.

Summary for Ucb Inc

International Patents:318
US Patents:15
Tradenames:32
Ingredients:24
NDAs:48
Drug Master File Entries: 1
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ucb IncNEUPROrotigotineFILM, EXTENDED RELEASE;TRANSDERMAL021829-002May 9, 2007RXYesNo► Subscribe► SubscribeY► Subscribe
Ucb IncBRIVIACTbrivaracetamTABLET;ORAL205836-001May 12, 2016RXYesNo► Subscribe► SubscribeYY► Subscribe
Ucb IncNEUPROrotigotineFILM, EXTENDED RELEASE;TRANSDERMAL021829-002May 9, 2007RXYesNo► Subscribe► SubscribeY► Subscribe
Ucb IncKEPPRAlevetiracetamTABLET;ORAL021035-002Nov 30, 1999ABRXYesNo► Subscribe► SubscribeY► Subscribe
Ucb IncNEUPROrotigotineFILM, EXTENDED RELEASE;TRANSDERMAL021829-004Apr 2, 2012RXYesNo► Subscribe► SubscribeY► Subscribe
Ucb IncNIRAVAMalprazolamTABLET, ORALLY DISINTEGRATING;ORAL021726-001Jan 19, 2005DISCNYesNo► Subscribe► SubscribeY► Subscribe
Ucb IncNEUPROrotigotineFILM, EXTENDED RELEASE;TRANSDERMAL021829-004Apr 2, 2012RXYesNo► Subscribe► SubscribeY► Subscribe
Ucb IncBRIVIACTbrivaracetamSOLUTION;INTRAVENOUS205837-001May 12, 2016RXYesYes► Subscribe► Subscribe► Subscribe
Ucb IncALBUTEROL SULFATEalbuterol sulfateTABLET;ORAL073121-001Sep 29, 1992DISCNNoNo► Subscribe► Subscribe► Subscribe
Ucb IncCO-GESICacetaminophen; hydrocodone bitartrateTABLET;ORAL087757-001May 3, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Ucb Inc

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ucb IncVIMPATlacosamideTABLET;ORAL022253-003Oct 28, 2008► Subscribe► Subscribe
Ucb IncKEPPRAlevetiracetamTABLET;ORAL021035-003Nov 30, 1999► Subscribe► Subscribe
Ucb IncVIMPATlacosamideTABLET;ORAL022253-004Oct 28, 2008► Subscribe► Subscribe
Ucb IncVIMPATlacosamideSOLUTION;ORAL022255-001Apr 20, 2010► Subscribe► Subscribe
Ucb IncKEPPRA XRlevetiracetamTABLET, EXTENDED RELEASE;ORAL022285-001Sep 12, 2008► Subscribe► Subscribe
Ucb IncUNIVASCmoexipril hydrochlorideTABLET;ORAL020312-002Apr 19, 1995► Subscribe► Subscribe
Ucb IncKEPPRAlevetiracetamTABLET;ORAL021035-002Nov 30, 1999► Subscribe► Subscribe
Ucb IncMYKROXmetolazoneTABLET;ORAL019532-001Oct 30, 1987► Subscribe► Subscribe
Ucb IncKEPPRAlevetiracetamSOLUTION;ORAL021505-001Jul 15, 2003► Subscribe► Subscribe
Ucb IncUNIVASCmoexipril hydrochlorideTABLET;ORAL020312-002Apr 19, 1995► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for UCB INC drugs

Drugname Dosage Strength Tradename Submissiondate
lacosamideInjection10 mg/mL, 20 mLVIMPAT6/30/2016
rotigotineExtended-release Transdermal Film1 mg/24 hr, 2 mg/24 hr, 3 mg/24 hr,4 mg/24 hr,6 mg/24 hr, and 8 mg/24 hrNEUPRO11/26/2013
lacosamideOral Solution10 mg/mLVIMPAT10/29/2012
lacosamideTablets50 mg, 100 mg, 150 mg, and 200 mgVIMPAT10/29/2012
levetiracetamExtended-release Tablets1000 mgKEPPRA XR1/7/2011
metformin hydrochlorideExtended-release Capsules40 mgMETADATE CD3/15/2007
levetiracetamTablets1000 mgKEPPRA1/24/2007
alprazolamOrally Disintegrating Tablets0.25 mg, 0.5 mg, 1 mg and 2 mgNIRAVAM12/27/2005
metformin hydrochlorideExtended-release Capsules10 mg, 20 mg and 30 mgMETADATE CD5/13/2005
moexipril hydrochloride and hydrochlorothiazideTablets7.5mg/12.5mg 15 mg/25 mg and 15 mg/12.5 mgUNIRETIC1/15/2004

Non-Orange Book Patents for Ucb Inc

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,863,316Extended release formulation of Levetiracetam► Subscribe
7,217,8262-oxo-1-pyrrolidine derivatives, process for preparing them and their uses► Subscribe
6,713,635 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses► Subscribe
6,048,899 Anticonvulsant enantiomeric amino acid derivatives► Subscribe
5,773,475 Anticonvulsant enantiomeric amino acid derivatives► Subscribe
7,692,0282-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses► Subscribe
7,358,2762-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses► Subscribe
6,969,770 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses► Subscribe
6,858,740 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses► Subscribe
6,806,287 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ucb Inc Drugs

Country Document Number Estimated Expiration
European Patent Office1524971► Subscribe
Australia2005325930► Subscribe
Mexico2007009088► Subscribe
Australia5214401► Subscribe
Bulgaria65783► Subscribe
Iceland2754► Subscribe
Germany60143493► Subscribe
Slovenia1265862► Subscribe
Norway20050770► Subscribe
Saudi Arabia1275► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Ucb Inc Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C/GB12/047United Kingdom► SubscribePRODUCT NAME: DEXAMETHASONE; REGISTERED: UK EU/1/10/638/001 20100727
C001/2009Ireland► SubscribeSPC001/2009: 20091013, EXPIRES: 20220316
00376Netherlands► SubscribePRODUCT NAME: LACOSAMIDE; REGISTRATION NO/DATE: EU/1/08/470/001-016 20080829
2016 00013Denmark► SubscribePRODUCT NAME: BRIVARACETAM; REG. NO/DATE: EU/1/15/1073/001-022 20160118
269Luxembourg► Subscribe91269, EXPIRES: 20210215
24/2006Austria► SubscribePRODUCT NAME: ROTIGOTINE
0443983/03Switzerland► SubscribePRODUCT NAME: VALSARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDE; REGISTRATION NUMBER/DATE: SWISSMEDIC 59407 16.09.2009
C/GB02/037United Kingdom► SubscribePRODUCT NAME: TELMISARTAN, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, AND HYDROCHLOROTHIAZIDE; REGISTERED: UK EU/1/02/213/001 20020419; UK EU/1/02/213/002 20020419; UK EU/1/02/213/003 20020419; UK EU/1/02/214/004 20020419; UK EU/1/02/213/005 20020419; UK EU/1/02/213/006 20020419; UK EU/1/02/213/007 20020419; UK EU/1/02/213/008 20020419; UK EU/1/02/213/009 20020419; UK EU/1/02/213/010 20020419
00236Netherlands► SubscribePRODUCT NAME: ROTIGOTINE; REGISTRATION NO/DATE: EU/1/05/331/001-013 20060215
/2006Austria► SubscribePRODUCT NAME: ROTIGOTINE; REGISTRATION NO/DATE: EU/1/05/331/001 - EU/1/05/331/013 20060215
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Julphar
Argus Health
Teva
McKinsey
Daiichi Sankyo
Covington
Deloitte
Novartis
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot